EODData

MEMBERSHIP REGISTER LOG IN

ASX, IMC: Immuron Ltd.

28 Nov 2025
LAST:

0.0640

CHANGE:
 0.00		OPEN:
0.0640		HIGH:
0.0640		ASK:
0.0730		VOLUME:
0
CHG(%):
3.03		PREV:
0.0660		LOW:
0.0640		BID:
0.0670		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Nov 250.06400.06400.06400.06400
27 Nov 250.06400.06400.06400.064054.4K
26 Nov 250.06500.06600.06500.0660100.0K
25 Nov 250.06400.06600.06400.066094.9K
24 Nov 250.06400.06500.06200.0650646.0K
21 Nov 250.06300.06300.06300.0630370.6K
20 Nov 250.06200.06400.06200.0640451.7K
19 Nov 250.06400.06400.06200.0620473.2K
18 Nov 250.06300.06300.06300.06300
17 Nov 250.06300.06300.06300.0630172.1K

PROFILE

Name:Immuron Ltd.
About:Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:62 Lygon Street, Carlton, VIC, Australia, 3053
Website:https://www.immuron.com.au
ISIN:AU000000IMC7
FIGI:BBG000C6G7Z1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-3.44 
Price to Sales:2.92 
Price to Book:2.32 
Profit Margin:-0.72 
Operating Margin:-0.86 
Return on Assets:-0.26 
Return on Equity:-0.50 
EPS Ratio:-0.02 
Revenue:7.29M 
Shares:268.22M 
Market Cap:17.17M 

TECHNICAL INDICATORS

MA5:0.061.3%
MA10:0.060.0%
MA20:0.076.6%
MA50:0.0821.4%
MA100:0.0714.8%
MA200:0.0710.6%
STO9:50.00
STO14:33.33
RSI14:37.50 
WPR14:-66.67
MTM14:0.00
ROC14:-0.02 
ATR:0.00 
Week High:0.073.1%
Week Low:0.063.2%
Month High:0.1053.1%
Month Low:0.0610.6%
Year High:0.1056.3%
Year Low:0.0518.5%
Volatility:74.71 

RECENT SPLITS

Date Ratio
16 Nov 20141-40